PUBLISHER: The Business Research Company | PRODUCT CODE: 1942514
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942514
The cardiac arrhythmia monitoring device serves as a tool for the continuous monitoring of irregular heartbeats, specifically addressing the condition of arrhythmia.
The primary categories of cardiac arrhythmia monitoring devices encompass various types, including standards in ambulatory cardiac monitoring, patient- and event-activated intermittent recorders, external loop recorders, pre-symptom memory loop cardiac event recorders, post-symptom event recorders, continuous real-time attended remote cardiac monitors, mobile cardiac outpatient telemetry systems, and vital signs transmitters like Bio Watch Medical. Standards in ambulatory cardiac monitoring involve the recording and detection of electrical activity in a patient's heart over extended periods. These devices, such as the Holter monitor, event recorder, mobile cardiac telemetry, implantable cardiac monitor, electrocardiogram (ECG) monitor, and others, play a crucial role in diagnosing arrhythmias, including irregular heart rhythms. These monitoring devices are utilized across diverse healthcare settings, including hospitals, clinics, diagnostic centers, ambulatory surgical centers, homecare settings, and other relevant facilities. They are instrumental in detecting conditions such as tachycardia, bradycardia, premature contractions, and others, contributing to comprehensive cardiac care.
Tariffs are impacting the cardiac arrhythmia monitoring devices market by increasing costs of imported sensors, semiconductors, wireless modules, batteries, and medical-grade electronics. Healthcare providers in North America and Europe are most affected due to dependence on imported device components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing device prices and slowing upgrade cycles. However, they are also driving localized electronics manufacturing, regional device assembly, and innovation in cost-optimized monitoring solutions.
The cardiac arrhythmia monitoring devices market research report is one of a series of new reports from The Business Research Company that provides cardiac arrhythmia monitoring devices market statistics, including cardiac arrhythmia monitoring devices industry global market size, regional shares, competitors with a cardiac arrhythmia monitoring devices market share, detailed cardiac arrhythmia monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac arrhythmia monitoring devices industry. This cardiac arrhythmia monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac arrhythmia monitoring devices market size has grown strongly in recent years. It will grow from $8.37 billion in 2025 to $9.19 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of cardiac arrhythmias, expansion of ambulatory monitoring usage, advancements in ECG sensor technologies, rising awareness of early cardiac diagnosis, increased adoption of telecardiology services.
The cardiac arrhythmia monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.16 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising investments in digital health platforms, expansion of ai-enabled arrhythmia detection, growing preference for homecare diagnostics, increasing integration with mobile health ecosystems. Major trends in the forecast period include increasing adoption of wearable cardiac monitoring devices, rising use of remote and home-based monitoring, growing integration of real-time data analytics, expansion of implantable monitoring solutions, enhanced focus on continuous long-term monitoring.
The growing prevalence of cardiovascular diseases is expected to drive growth in the cardiac arrhythmia monitoring devices market in the coming years. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including atherosclerosis, angina, heart attacks, and aortic disease. Cardiac arrhythmia monitoring devices track the electrical activity of the heart (ECG) to detect irregular heartbeats and assess the risk of arrhythmias. For example, in April 2023, HMP Global, a US-based patient-centered education company, projected that the prevalence of peripheral arterial disease in the United States would rise to 23.8 million by 2030, up from 21.0 million in 2020. Consequently, the increasing prevalence of cardiovascular diseases is supporting growth in the cardiac arrhythmia monitoring devices market.
Major companies operating in the cardiac arrhythmia monitoring devices market are focusing on product innovations, particularly in insertable cardiac monitoring systems. These small, implantable devices continuously record the heart's electrical activity, providing long-term diagnostic data to detect arrhythmias and other cardiovascular conditions. For instance, in October 2023, Boston Scientific Corporation, a US-based medical equipment manufacturer, launched the LUX-Dx II+ Insertable Cardiac Monitor System. The device features dual-stage algorithms to detect and verify potential arrhythmias before alerting clinicians, remote programming capabilities, and customizable algorithms for various cardiac conditions. It also reduces false positives and irrelevant episodes, while a downloadable app enables patients to conveniently monitor their heart remotely.
In May 2024, WearLinq, a US-based digital healthcare company, acquired AMI Cardiac Monitoring for an undisclosed amount. This acquisition enhances WearLinq's ability to provide clinical services for cardiac patients. AMI Cardiac Monitoring, a US-based independent diagnostic testing facility, offers cardiac arrhythmia monitoring devices for patients seeking reliable heart rhythm tracking.
Major companies operating in the cardiac arrhythmia monitoring devices market are AliveCor Inc., Biotronik SE & Co. KG, General Electric Company, iRhythm Technologies Inc., Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Abbott Laboratories, Hill-Rom Holdings Inc., Applied Cardiac System Diagnostics Inc., Biotricity Inc., Boston Scientific Corporation, Medicalgorithmics S.A., Siemens AG, Fukuda Denshi Co. Ltd., NUUBO SMART SOLUTIONS S.L., Cardiac Insight Inc., CardioComm Solutions Inc., MicroPort Scientific Corporation, Osypka AG, Spacelabs Healthcare
North America was the largest region in the cardiac arrhythmia monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cardiac arrhythmia monitoring devices market report during the forecast period. The regions covered in the cardiac arrhythmia monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac arrhythmia monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiac arrhythmia monitoring devices market consists of sales of wireless holter monitors, post-event recorder patch recorders, autodetect recorders, implanted loop recorders, remote monitoring of pacemakers, implantable cardioverter-defibrillators, real-time telemetry devices, and insertable loop recorders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Arrhythmia Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac arrhythmia monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac arrhythmia monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac arrhythmia monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.